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SUmmaRy Recently, family history and increased frequency of some isolated 
manifestations of the disease in relatives of patients have been thought to 
play an important role in the etiopathogenesis of Behçet’s disease (BD). Fam-
ily history has been proposed to participate in diagnostic criteria. Investigat-
ing features of patients with different family histories may give an additional 
insight in understandings BD. The aim of this study was to explore the effect 
of familial occurrence and family history of recurrent oral ulcers (ROUs) on the 
clinical features of BD. We analyzed retrospectively 141 BD patients according 
to the International Study Group criteria. Family history of BD was present in 
31.2%, family history of ROUs without BD in 31.9%, and negative family his-
tory for BD and ROUs in 36.9% of study patients. All patients were evaluated 
with respect to demographic and clinical features. There was no significant 
difference in most clinical features among patients with different family his-
tories (p>0.05). Besides, patients with family history of BD and/or ROUs had 
longer duration of ROUs before diagnosis and more frequent extragenital ul-
cers than patients with negative family history of BD and ROUs (p<0.05 and 
p<0.01, respectively). These findings did not show any strong effect of familial 
occurrence or positive family history of ROUs on all clinical characteristics of 
BD. However, sporadic ROUs should be considered an early predictor of prob-
able BD in patients with family history of BD and/or ROUs, and they should 
be followed up carefully. Further studies including genetic testing of patients 
and their relatives are needed. 
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IntRODUCtIOn
Behçet’s disease (BD) is a multisystem disorder 
of unknown origin characterized by recurrent oral 
ulcers (ROUs), mucocutaneous disorders and ocular 
findings. Also, BD may affect central nervous system, 
large vessels and gastrointestinal tract, and even 
may be life-threatening (1,2). Environmental, infec-
tious and genetic factors have been proposed to 
act as the main contributors in the outbreak of BD. 
The etiopathogenesis of BD has been investigated in 
many studies for a long time but the exact etiology 
and mechanisms of pathogenesis have not yet been 
clarified (1). Genetic researches showed strong asso-
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ciation with HLA-B51 and TNF-α, IL-10 vs. IL-23R gene 
polymorphisms were also indicated. However, the ex-
act genetic mechanisms have not been described for 
all patients (1,3-5).
Recently, considering clinical and immunolog-
ic properties of BD, the disease is thought to be a 
cornerstone between autoimmune and inflamma-
tory diseases. Association with HLA, immunologic 
properties and presence of autoantibodies support 
autoimmunity, however, clinical features and male 
predominance suggest inflammatory disease (1). 
Some studies assert that characteristics and severity 
of the disease have been changed over years. Also, 
subtypes of BD have been discussed (6,7). Behçet’s 
disease does not have a specific diagnostic feature or 
a laboratory method, therefore clinical characteristics 
and symptoms are the main factors for management 
of BD. Thus, investigations of its prevalence and clini-
cal features should be performed periodically in the 
countries with a high prevalence of BD to follow the 
changing dynamics of the disease, which may also 
lead to refinements in the unexplained pathogenesis 
of BD. From these aspects, also, cohort studies from 
different geographical regions are worthwhile.
Recently, family history has been thought to play 
an important role in the etiopathogenesis of BD and 
has been proposed to participate in diagnostic crite-
ria, especially in pediatric BD (5,8,9). Clinical features 
of familial BD and increased frequency of some isolat-
ed manifestations of the disease in relatives of BD pa-
tients have been investigated in a few studies (9,10). 
Investigating the features of patients with different 
family histories may give an insight into understand-
ing BD. In this study, we aimed to explore the effect 
of familial occurrence and family history of ROUs on 
demographic and clinical features of BD. 
mateRIal anD metHODS
The study included 141 patients with BD who 
attended Departments of Dermatology in Kayseri 
Gunes Hospital and Yozgat Bozok University Medical 
Faculty between 2006 and 2011. The hospitals were 
in two different cities in central Anatolia, Turkey. All 
patients were examined by dermatologists, ophthal-
mologists, and if necessary by internal medicine or 
physical and rehabilitation specialists, cardiovascular 
surgeon or neurologist. Establishment of diagnos-
tic criteria was done according to the International 
Study Group for BD (11). Demographic data and clini-
cal characteristics of all patients were evaluated retro-
spectively from their medical records. In addition, age 
at onset, duration of ROUs before diagnosis, and fam-
ily history of BD and ROUs were evaluated. According 
to patient medical reports, a first degree relative with 
BD or ROUs was accepted as a positive family history. 
Patients were divided into three groups according to 
their family history: group I – patients with family his-
tory of BD with/without ROUs; group II – patients who 
had only ROUs in family history; and group III – pa-
tients with negative family history of BD and ROUs.
Pathergy testing was performed by a 12-gauge 
sterile needle puncture on the forearm and assessed 
by dermatologist at initial examination. Papule, pus-
tule, or papule surrounded by adjacent erythema 
were considered as positive reaction. 
SPSS 17.0 (SPSS Inc., Chicago, IL, USA) was used 
on statistical analyses, while between-group compar-
isons were assessed by use of χ2-test, Mann-Whitney 
U test and one-way ANOvA test. 
ReSUltS
Out of 141 patients, there were 71 (53.9%) male 
and 65 (46.1%) female patients, with a male to female 
ratio of 1.16. Their mean age was 33.8±9.69 and mean 
age at onset 29.77±8.56 years. The mean duration of 
ROUs before diagnosis of BD was 7.75 years. Pathergy 
positivity was present in 41.1% of patients and ROUs 
were obtained in all patients (100%). Genital ulcer was 
observed in 83%, erythema nodosum in 46.8%, acne-
iform eruption in 73.8%, superficial thrombophlebitis 
in 16.3%, extragenital ulcer in 10.6%, eye involvement 
in 33.3%, arthritis/arthralgia in 72.3%, neurologic in-
volvement in 2.8% and large vessel involvement in 
10.6% of all patients. There was no patient with gas-
trointestinal system involvement. Groups I, II and III 
consisted of 44 (31.2%), 45 (31.9%) and 52 (36.9%) 
patients, respectively. All 44 group I patients had 
both BD and ROUs, while 14 had only BD in their first-
degree relatives. There was no statistically significant 
between-group difference according to sex, age and 
age at onset of the disease (p>0.05). Statistical analy-
sis comparing differences in pathergy positivity and 
clinical manifestations of BD revealed no significant 
between-group difference (p>0.05). However, group 
I and group II patients had longer duration of ROUs 
before diagnosis of BD and more frequent extrageni-
tal ulcers than group III patients (p<0.05 and p<0.01, 
respectively). Demographic data, clinical manifesta-
tions and pathergy positivity of all groups are sum-
marized in Table 1. 
Clinical manifestations and pathergy positivity 
were evaluated according to sex. No statistically sig-
nificant sex differences were detected in patient age, 
age at onset and duration of ROUs before diagnosis 
of BD. The frequencies of all clinical manifestations 
except for eye involvement and pathergy positivity 
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showed no significant differences between male and 
female patients either (p>0.05). Eye involvement and 
pathergy positivity were more common in male pa-
tients (p<0.01 and p<0.05, respectively). These data 
are shown in Table 2.
DISCUSSIOn
The epidemiology of BD has remarkable proper-
ties. The high prevalence of BD in ancient Silk Road 
has been known for a long time. However, the inci-
dence of BD decreases among immigrants from high 
prevalence regions (5,12). So, environmental trigger-
ing factors seem to be as important as genetic sus-
ceptibility. On the other hand, a wide spectrum of 
clinical manifestations are observed even in patients 
with similar genetic background and environmental 
factors. Familial BD is important in the epidemiol-
ogy, with the reported prevalence of 15.4% in Korea, 
13.2% in Jews, 2.6% in China, 2.2% in Japan and 1% 
in Europe (5,7,13). Familial aggregations differ in vari-
ous regions, especially familial cases are common in 
regions with a high prevalence of BD. Studies from 
Turkey show the prevalence of familial BD of 34%, 
25.8%, 22.4%, 18% and 7.3% (3,9,14). Familial BD is 
more common in pediatric patients and frequencies 
of 30.7% and 47% have been reported in two stud-
ies (5,15). In one series, 12.3% of pediatric BD cases 
and only 2.2% of non-pediatric patients had a fam-
ily history of BD (16). An investigation showed λs val-
ues of 11.4-52.5 for BD resembling the high sibling 
recurrence risk ratio in Turkey. However, it has been 
claimed that an increased prevalence of familial ag-
gregation in juvenile BD may define a subgroup with 
stronger genetic effects (9).
In our study, familial BD was found in 44 (31.2%) 
patients and 30 of them also had a family history of 
ROUs. Five of our 141 patients were pediatric BD (age 
≤16 years). One of them had a family history of BD, 
three patients had a family history of ROUs, and one 
patient had negative family history for BD and ROUs. 
Also, 31.9% of our patients had a family history of 
ROUs without BD. In a study from Turkey, the rate of 
familial BD was 12.2% and of family history of ROUs 
without BD 13.6% (14).
Recurrent oral ulcers are the major diagnostic cri-
terion and a sine qua non of BD; they appear in almost 
all patients, and according to the general opinion, 
they frequently are the first systemic manifestation of 
the disease (17). However, ROUs are not specific for 
BD and there are numerous causes of ROUs. Recur-
rent oral ulcers may occur in 0.5% to 40% of the gen-
eral population and clustering of familial cases were 
demonstrated (3,18-21). Behçet’s disease is a com-
mon diagnosis in cases of ROUs with early onset and 
table 1. Demographic features and clinical manifestations in patients according to family history
Positive family 
history for BD 
(group I)
Positive family 





BD or ROUs 
(group III) Total p
Number of patients 44 45 52 141
Male 27 21 28 76 0.498
Female 17 24 24 65 0.498
Mean (±SD) patient age (yrs) 34.38±9.78 33.26±10.79 33.9±8.74 33.85±9.69 0.952
Mean (±SD) patient age at BD onset (yrs) 29.38±8.65 28.80±8.9 30.94±8.65 29.7±8.56 0.217
Mean (±SD) duration of ROUs before 
diagnosis (yrs)
9.26±5.53 7.71±4.9 6.48±3.92 7.75±4.88 0.018*
Pathergy positivity 21 20 17 58 0.283
Genital ulcer 39 36 42 117 0.324
Erythema nodosum 22 26 18 66 0.065
Acneiform eruption 33 32 39 104 0.887
Superficial thrombophlebitis 7 10 6 23 0.363
Extragenital ulcer 1 10 4 15 0.007*
Eye involvement 16 15 16 47 0.845
Arthritis/arthralgia 36 28 38 102 0.117
Neurological involvement 2 2 0 4 0.3
Gastrointestinal system 0 0 0 0 -
Large vessel involvement 3 6 6 15 0.588
*statistically significant difference; BD = Behçet’s disease; ROUs = recurrent oral ulcers
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table 1. Demographic features and clinical manifestations in patients according to family history
in presence of multiple oral ulcerations. In one study, 
no significant difference was recorded in the frequen-
cy of familial cases between ROUs and BD (20). In an-
other study, patients with a positive family history 
showed an earlier age at onset of ROU episodes and 
more severe symptoms than patients with negative 
history (19). In a series study from Turkey, 47 of 1238 
(3%) patients with ROUs were diagnosed as BD with a 
mean duration of 5.61 years (22). In a Korean study, 35 
of 67 (52.2%) patients with ROUs were diagnosed as 
BD in 7.7 years (21). In our study, the mean duration of 
ROUs before the diagnosis of BD was 7.75 years. 
Alli et al. mention that a high prevalence of iso-
lated manifestations of the disease, such as recurrent 
orogenital ulcers or a positive skin pathergy test, was 
also observed among patient first-degree relatives 
who probably were low-penetrant carriers of predis-
posing genes. But, the high prevalence of ROUs in 
the general population should be taken into account. 
Additionally, they did not observe earlier age at onset 
in patients with a family history of BD or ROUs (14). It 
was consistent with our results. However, in one study, 
the age at onset was lower in familial BD (16). Another 
investigation revealed an early onset of familial BD 
with ocular involvement (7). Besides this, our patients 
with a family history of BD and/or ROUs had a longer 
duration of ROUs before the diagnosis of BD. It was 
compatible with the general belief that an early onset 
of ROUs with a family history of BD and ROUs is more 
likely to be a predictor of BD (8,15,20). Sporadic ROUs 
should be considered as an early predictor of prob-
able BD in patients with a family history of BD and/or 
ROUs and they should be followed up carefully. 
Alli et al. found no statistically significant rela-
tionship between activity scores and family history. 
However, the frequencies of clinical manifestations of 
familial and non-familial cases were not assessed (14). 
Nishiyama et al. report on the early onset of familial BD 
with ocular involvement but they did not assess the 
frequencies of all clinical manifestations either. They 
point out that a large-scale epidemiological study of 
familial BD patients is also needed to elucidate the 
etiology of the disease (7). In the current study, we 
aimed to explore the effect of familial occurrence and 
family history of ROUs on all clinical features of BD. 
The rates of pathergy positivity did not show any sig-
nificant difference among the three groups with dif-
ferent family histories. We did not find any significant 
difference in most clinical features between patients 
with different family histories (p>0.05). Besides, pa-
tients with a family history of BD and/or ROUs had 
more frequent extragenital ulcers than patients with 
negative family history of BD and ROUs (p<0.01). Ex-
tragenital ulcer was found in 15/141 of our patients. 
One of the 15 patients with extragenital ulcer had a 
family history of BD with/without ROUs, ten patients 
had a family history of ROUs without BD, and four pa-
tients had negative family history of BD and ROUs. Ex-
tragenital ulcers are one of the cutaneous lesions of 
BD. Cutaneous lesions are an important feature of the 
disease and have been described by the International 
Study Group for Behcet’s Disease as a major criterion 
for the diagnosis (11). Further reports on BD may as-
sert the impact and specificity of extragenital ulcers 
in the diagnosis and genetic background. 
Female Male Total p
Number of patients 65 76 141 0.498
Mean (±SD) patient age (yrs) 34.18±9.3 33.4±10.04 33.85±9.69 0.884
Mean (±SD) patient age at BD onset (yrs) 29.68±8.2 29.87±9,0 29.7±8.56 0.451
Mean (±SD) duration of ROUs before diagnosis (yrs) 7.7±4.92 7.67±4.83 7.75±4.88 0.260
Pathergy positivity 16 42 58 0.00*
Genital ulcer 58 59 117 0.553
Erythema nodosum 35 31 66 0.84
Acneiform eruption 50 54 104 0.276
Superficial thrombophlebitis 11 12 23 0.517
Extragenital ulcer 8 7 15 0.373
Eye involvement 15 32 47 0.013*
Arthritis/arthralgia 47 55 102 0.571
Neurological involvement 1 3 4 0.371
Gastrointestinal system involvement 0 0 0 -
Large vessel involvement 4 11 15 0.091
*statistically significant difference; BD = Behçet’s disease; ROUs = recurrent oral ulcers
table 2. Demographic features and clinical manifestations in patients according to sex
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Some studies determined higher rates of pather-
gy positivity among male patients with BD (14,23). 
We also observed higher rates of pathergy positivity 
among males. In our study, the frequency of ocular 
involvement was also higher in males and it was con-
sistent with some studies in the literature (23,24).
Herein we analyzed all demographic and clinical 
features of our patients with BD according to differ-
ent family histories. We hypothesized that familial BD 
may present different clinical spectrum from a non-
familial patient. Also, a patient with a family history of 
ROUs may have different clinical features of BD than a 
patient with negative family history. In the literature, 
a few studies investigated some features of familial 
BD (7,14), while some others report isolated manifes-
tations of BD in relatives of BD patients (5,9,14). In-
deed, BD has interrelated demographic, genetic and 
clinical properties (1,12). Interestingly enough, ROUs, 
which are the major feature as a diagnostic criterion 
for BD, also have interrelated demographic, genetic 
and clinical properties (21,25). Familial cases are im-
portant in the pathogenesis and prognosis of both 
diseases (5,7,14,20). However, ROUs do not show geo-
graphical clustering but show horizontal transmis-
sion (17). So, advanced studies are needed to clarify 
the relationship of BD and ROUs. Genetic analysis was 
not included in our study and this was an important 
limitation of the study. Additional studies including 
genetic testing of patients and their relatives may be 
worthy. 
COnClUSIOn
Our findings did not show any strong effect of fa-
milial occurrence or positive family history of ROUs 
on any clinical characteristic of BD. However, sporadic 
ROUs should be considered as an early predictor of 
probable BD in patients with a family history of BD 
and/or ROUs and they should be followed up care-
fully.
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